Annual Current Liabilities
$49.81 M
+$10.54 M+26.84%
December 31, 2023
Summary
- As of February 20, 2025, ADMA annual total current liabilities is $49.81 million, with the most recent change of +$10.54 million (+26.84%) on December 31, 2023.
- During the last 3 years, ADMA annual current liabilities has risen by +$29.86 million (+149.69%).
- ADMA annual current liabilities is now at all-time high.
Performance
ADMA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$44.89 M
+$714.00 K+1.62%
September 30, 2024
Summary
- As of February 20, 2025, ADMA quarterly total current liabilities is $44.89 million, with the most recent change of +$714.00 thousand (+1.62%) on September 30, 2024.
- Over the past year, ADMA quarterly current liabilities has stayed the same.
- ADMA quarterly current liabilities is now -15.44% below its all-time high of $53.09 million, reached on March 31, 2024.
Performance
ADMA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ADMA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.8% | 0.0% |
| 3 y3 years | +149.7% | +14.3% |
| 5 y5 years | +417.5% | +14.3% |
ADMA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.0% | -15.4% | +59.9% |
| 5 y | 5-year | at high | +255.1% | -15.4% | +248.5% |
| alltime | all time | at high | >+9999.0% | -15.4% | >+9999.0% |
ADMA Biologics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.89 M(+1.6%) |
| Jun 2024 | - | $44.18 M(-16.8%) |
| Mar 2024 | - | $53.09 M(+6.6%) |
| Dec 2023 | $49.81 M(+26.8%) | $49.81 M(+19.0%) |
| Sep 2023 | - | $41.84 M(-0.3%) |
| Jun 2023 | - | $41.95 M(+14.2%) |
| Mar 2023 | - | $36.73 M(-6.5%) |
| Dec 2022 | $39.27 M(+29.3%) | $39.27 M(-11.6%) |
| Sep 2022 | - | $44.44 M(+58.3%) |
| Jun 2022 | - | $28.07 M(-11.1%) |
| Mar 2022 | - | $31.57 M(+3.9%) |
| Dec 2021 | $30.38 M(+52.3%) | $30.38 M(-6.1%) |
| Sep 2021 | - | $32.34 M(+77.8%) |
| Jun 2021 | - | $18.19 M(-14.2%) |
| Mar 2021 | - | $21.21 M(+6.3%) |
| Dec 2020 | $19.95 M(+42.2%) | $19.95 M(+21.1%) |
| Sep 2020 | - | $16.47 M(+27.9%) |
| Jun 2020 | - | $12.88 M(-7.4%) |
| Mar 2020 | - | $13.91 M(-0.9%) |
| Dec 2019 | $14.03 M(+45.7%) | $14.03 M(-7.4%) |
| Sep 2019 | - | $15.15 M(+49.6%) |
| Jun 2019 | - | $10.13 M(+21.5%) |
| Mar 2019 | - | $8.34 M(-13.4%) |
| Dec 2018 | $9.63 M(+2.0%) | $9.63 M(-2.7%) |
| Sep 2018 | - | $9.89 M(+43.0%) |
| Jun 2018 | - | $6.92 M(-26.7%) |
| Mar 2018 | - | $9.44 M(+0.0%) |
| Dec 2017 | $9.44 M | $9.44 M(-29.2%) |
| Sep 2017 | - | $13.34 M(-14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $15.64 M(+20.7%) |
| Mar 2017 | - | $12.96 M(+15.5%) |
| Dec 2016 | $11.22 M(+166.2%) | $11.22 M(+21.9%) |
| Sep 2016 | - | $9.21 M(+81.2%) |
| Jun 2016 | - | $5.08 M(+18.4%) |
| Mar 2016 | - | $4.29 M(+1.8%) |
| Dec 2015 | $4.22 M(+0.4%) | $4.22 M(-1.9%) |
| Sep 2015 | - | $4.30 M(+34.3%) |
| Jun 2015 | - | $3.20 M(-15.5%) |
| Mar 2015 | - | $3.79 M(-9.8%) |
| Dec 2014 | $4.20 M(+14.8%) | $4.20 M(+1.9%) |
| Sep 2014 | - | $4.12 M(+8.5%) |
| Jun 2014 | - | $3.80 M(-11.8%) |
| Mar 2014 | - | $4.30 M(+17.6%) |
| Dec 2013 | $3.66 M(+101.3%) | $3.66 M(+45.3%) |
| Sep 2013 | - | $2.52 M(+24.1%) |
| Jun 2013 | - | $2.03 M(-3.4%) |
| Mar 2013 | - | $2.10 M(+15.6%) |
| Dec 2012 | $1.82 M(>+9900.0%) | $1.82 M(+29.5%) |
| Sep 2012 | - | $1.40 M(+39.6%) |
| Jun 2012 | - | $1.01 M(-2.1%) |
| Mar 2012 | - | $1.03 M(>+9900.0%) |
| Dec 2011 | - | $5300.00(-45.9%) |
| Sep 2011 | - | $9800.00(0.0%) |
| Jun 2011 | $9800.00(-21.0%) | $9800.00(+69.0%) |
| Mar 2011 | - | $5800.00(+20.8%) |
| Dec 2010 | - | $4800.00(-61.3%) |
| Jun 2010 | - | $12.40 K |
| Jun 2010 | $12.40 K | - |
FAQ
- What is ADMA Biologics annual total current liabilities?
- What is the all time high annual current liabilities for ADMA Biologics?
- What is ADMA Biologics annual current liabilities year-on-year change?
- What is ADMA Biologics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ADMA Biologics?
- What is ADMA Biologics quarterly current liabilities year-on-year change?
What is ADMA Biologics annual total current liabilities?
The current annual current liabilities of ADMA is $49.81 M
What is the all time high annual current liabilities for ADMA Biologics?
ADMA Biologics all-time high annual total current liabilities is $49.81 M
What is ADMA Biologics annual current liabilities year-on-year change?
Over the past year, ADMA annual total current liabilities has changed by +$10.54 M (+26.84%)
What is ADMA Biologics quarterly total current liabilities?
The current quarterly current liabilities of ADMA is $44.89 M
What is the all time high quarterly current liabilities for ADMA Biologics?
ADMA Biologics all-time high quarterly total current liabilities is $53.09 M
What is ADMA Biologics quarterly current liabilities year-on-year change?
Over the past year, ADMA quarterly total current liabilities has changed by $0.00 (0.00%)